Shire plans to acquire Belgian Movetis for €428m

British pharmaceutical company Shire has made an offer to acquire Belgian pharmaceutical company Movetis for 428 million euros (565 million US dollars). Movetis specializes in the development and production of medicines for the treatment of gastrointestinal diseases.

Leave a Comment

Your email address will not be published. Required fields are marked *